What is Imperative Care?
Imperative Care is a medical technology company dedicated to developing and commercializing connected innovations designed to enhance the care of individuals affected by stroke and other ischemic vascular diseases. The company is recognized as a burgeoning innovator in the medtech sector, offering a suite of interventional solutions aimed at addressing critical needs throughout the patient care continuum. By integrating digital health and robotics, Imperative Care seeks to broaden access to advanced medical treatments and improve patient outcomes for those managing complex vascular conditions.
How much funding has Imperative Care raised?
Imperative Care has raised a total of $445M across 3 funding rounds:
Series C
$85M
Series D
$260M
Debt
$100M
Series C (2019): $85M with participation from Delos Capital, Incept LLC, Ally Bridge Group, Bain Capital, 3H Health Investment, Ascension Ventures, and Rock Springs Capital
Series D (2021): $260M led by Bain Capital Life Sciences, Innovatus Capital Partners, Ally Bridge Group, HealthCor Investments, and D1 Capital Partners
Debt (2026): $100M supported by Longaeva Books, Elevage Medical Technologies, Ally Bridge Group, Brown Advisory, Catalio Capital Management, Bain Capital, and Perceptive Advisors
Key Investors in Imperative Care
Delos Capital
Delos Capital is a private equity firm based in New York City that specializes in private investment and financial advisory services, focusing on complex transactions and tailored solutions.
Ally Bridge Group
Ally Bridge Group is a global healthcare investment management firm specializing in high-impact life science innovation, managing over $6 billion in transactions since 2013.
Bain Capital
Founded in 1984, Bain Capital is one of the world's leading private investment firms committed to creating lasting impact across its global platform.
What's next for Imperative Care?
The recent major strategic investment in Imperative Care signals a pivotal moment for the company, likely enabling accelerated product development, market expansion, and further integration of its digital health and robotics initiatives. This infusion of capital is expected to bolster its efforts to address critical gaps in stroke and vascular disease treatment, positioning the company for significant growth and impact in the healthcare industry.
See full Imperative Care company page
